Get more information on Dialysis Market - Request Free Sample Report
The Dialysis Market was valued at USD 98.55 Bn in 2023 and is expected to reach USD 190.53 Bn by 2032 and grow at a CAGR of 7.6% over the forecast period of 2024-2032.
Dialysis is a medical therapy that assists the kidneys in performing their tasks when they are no longer able to do so properly. The kidneys' major role is to filter waste materials, excess fluids, and electrolytes from the blood while also maintaining a good chemical balance in the body. Dialysis is used to accomplish these critical processes artificially when the kidneys are damaged or not functioning adequately owing to illnesses such as kidney failure or end-stage renal disease (ESRD).
There are two types of dialysis, Hemodialysis: The patient's blood is pumped out of their body and through a machine called a dialyzer or hemodialyzer during hemodialysis. This equipment filters the blood to eliminate waste products and excess fluids, acting as an artificial kidney. After cleaning, the blood is returned to the patient's body. Hemodialysis is typically done in a dialysis center, and each session can last several hours. It is usually done three times per week.
Peritoneal Dialysis: This type of dialysis is done inside the body. A catheter is inserted into the patient's abdominal cavity, and dialysate, a specific fluid, is delivered into the peritoneal cavity. This fluid aids in the removal of waste materials and excess fluids from the peritoneum (the lining of the abdominal cavity).
Driver
The rise in the need of the dialysis treatment.
Over time, there is a gradual and cumulative decline of kidney function. Diabetes, high blood pressure (hypertension), autoimmune diseases, and some genetic disorders can also cause it. Diabetes is one of the most common causes of renal failure. High blood sugar levels can damage the blood vessels in the kidneys over time, limiting their ability to function correctly.
Restrain
The adverse health status of the patient which disqualifies them for dialysis.
Opportunity
Rise in the research and funding from the government.
Governments frequently control and supervise the quality of dialysis services supplied, ensuring that standards of care are met and patients receive safe and effective therapy. Some governments may grant funds for research and innovation in the field of renal care, which can lead to breakthroughs in dialysis technology and treatment approaches.
Challenge
The limited resources which include economic factors, lack of infrastructure.
Recessions can have a variety of effects on dialysis and the healthcare system as a whole. The intensity and duration of the recession, as well as the healthcare policies and infrastructure in place, can all have an impact on the magnitude of these consequences. Here are some of the ways a recession could influence dialysis.
Recessions frequently result in job losses, lower income, and financial troubles for individuals and families. For dialysis patients, the costs of treatment, including sessions, drugs, and related medical bills, may become even more expensive. During a recession, people may have difficulty accessing healthcare services due to factors such as reduced insurance coverage, fewer available medical facilities, and lengthier treatment wait lists.
Inflict can cause harm or ruin to healthcare facilities such as dialysis centers and hospitals. As a result, the capacity to deliver dialysis therapy to patients in affected locations may be diminished. The violence may interrupt international supply chains for medical equipment like as dialysis machines, pharmaceuticals, and other supplies. This could result in shortages or delays in getting necessary materials for dialysis treatment.
Conflict-related population displacement might result in the migration of patients who require regular dialysis treatment. This can make it difficult for them to receive consistent and timely care.
By Type
Hemodialysis
Peritoneal Dialysis
By Product
Equipment
Consumables
Drugs and Services
By End User
Incenter Dialysis
Home Dialysis
Regional Analysis
North America is one of the world's largest dialysis markets. Examine the market size and historical growth rates, taking into account factors such as the aging population, the increased frequency of chronic kidney disease (CKD), and advances in dialysis technology. The access of the healthcare for the patients suffering from kidney is easier compared to other regions. Also, the infrastructure and the facilities contribute to the growth of the dialysis market in this region.
APAC will be the region with the highest CAGR growth rate, due to reasons such as the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD), as well as developments in healthcare infrastructure, APAC is a rapidly growing market for dialysis.
Need any customization research on Dialysis Market - Enquiry Now
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
The major key players are Asahi Kasei, Nikkiso, Fresenius Se and CO, KGAA, Nipro Corporation, Becton, Dickinson and Company, Diaverum, Deutschland, Baxter International, B Braun Melesungen.
Asahi Kasei – The acquisition of Bionova Scientifics by the company I order to improve its current offerings.
Baxter International- The company has officially announced strategic actions in order to improve the operations effectiveness, and accelerate innovation.
| Report Attributes | Details |
| Market Size in 2023 | US$ 98.55 Bn |
| Market Size by 2032 | US$ 190.53 Bn |
| CAGR | CAGR of 7.6% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type (Hemodialysis, Peritoneal Dialysis) • By Product (Equipment, Consumables, Drugs and Services) • By End User (Incenter Dialysis, Home Dialysis) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]). Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia Rest of Latin America) |
| Company Profiles | Asahi Kasei, Nikkiso, Fresenius Se and CO, KGAA, Nipro Corporation, Becton, Dickinson and Company, Diaverum, Deutschland, Baxter International, B Braun Melesungen. |
| Key Drivers | • The rise in the need of the dialysis treatment. |
| Market Restraints | • The adverse health status of the patient which disqualifies them for dialysis. |
Ans: The Dialysis Market is expected to grow at a CAGR of 7.6%.
Ans: The Dialysis Market was valued at USD 98.55 Bn in 2023 and is expected to reach USD 190.53 Bn by 2032 and grow at a CAGR of 7.6% over the forecast period of 2024-2032.
Ans: The rise in the need of the dialysis treatment.
Ans: The adverse health status of the patient which disqualifies them for dialysis.
Ans: North America overtook other regional markets as the largest market for Dialysis, with the highest revenue share.
Table of Contents
1. Introduction
1.1 Market Definition
1.2 Scope
1.3 Research Assumptions
2. Research Methodology
3. Market Dynamics
3.1 Drivers
3.2 Restraints
3.3 Opportunities
3.4 Challenges
4. Impact Analysis
4.1 Impact of Russia-Ukraine War
4.2 Impact of Ongoing Recession
4.2.1 Introduction
4.2.2 Impact on major economies
4.2.2.1 US
4.2.2.2 Canada
4.2.2.3 Germany
4.2.2.4 France
4.2.2.5 United Kingdom
4.2.2.6 China
4.2.2.7 Japan
4.2.2.8 South Korea
4.2.2.9 Rest of the World
5. Value Chain Analysis
6. Porter’s 5 forces model
7. PEST Analysis
8. Dialysis Market, By Type
8.1 Hemodialysis
8.2 Peritoneal Dialysis
9. Dialysis Market, By Product
9.1 Equipment
9.2 Consumables
9.3 Drugs and Services
10. Dialysis Market, By End User
10.1 Incenter Dialysis
10.2 Home Dialysis
11. Regional Analysis
11.1 Introduction
11.2 North America
11.2.1 North America Dialysis Market by Country
11.2.2North America Dialysis Market by Type
11.2.3 North America Dialysis Market by Product
11.2.4 North America Dialysis Market by End User
11.2.5 USA
11.2.5.1 USA Dialysis Market by Type
11.2.5.2 USA Dialysis Market by Product
11.2.5.3 USA Dialysis Market by End User
11.2.6 Canada
11.2.6.1 Canada Dialysis Market by Type
11.2.6.2 Canada Dialysis Market by Product
11.2.6.3 Canada Dialysis Market by End User
11.2.7 Mexico
11.2.7.1 Mexico Dialysis Market by Type
11.2.7.2 Mexico Dialysis Market by Product
11.2.7.3 Mexico Dialysis Market by End User
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Eastern Europe Dialysis Market by country
11.3.1.2 Eastern Europe Dialysis Market by Type
11.3.1.3 Eastern Europe Dialysis Market by Product
11.3.1.4 Eastern Europe Dialysis Market by End User
11.3.1.5 Poland
11.3.1.5.1 Poland Dialysis Market by Type
11.3.1.5.2 Poland Dialysis Market by Product
11.3.1.5.3 Poland Dialysis Market by End User
11.3.1.6 Romania
11.3.1.6.1 Romania Dialysis Market by Type
11.3.1.6.2 Romania Dialysis Market by Product
11.3.1.6.4 Romania Dialysis Market by End User
11.3.1.7 Turkey
11.3.1.7.1 Turkey Dialysis Market by Type
11.3.1.7.2 Turkey Dialysis Market by Product
11.3.1.7.3 Turkey Dialysis Market by End User
11.3.1.8 Rest of Eastern Europe
11.3.1.8.1 Rest of Eastern Europe Dialysis Market by Type
11.3.1.8.2 Rest of Eastern Europe Dialysis Market by Product
11.3.1.8.3 Rest of Eastern Europe Dialysis Market by End User
11.3.2 Western Europe
11.3.2.1 Western Europe Dialysis Market by Country
11.3.2.2 Western Europe Dialysis Market by Type
11.3.2.3 Western Europe Dialysis Market by Product
11.3.2.4 Western Europe Dialysis Market by End User
11.3.2.5 Germany
11.3.2.5.1 Germany Dialysis Market by Type
11.3.2.5.2 Germany Dialysis Market by Product
11.3.2.5.3 Germany Dialysis Market by End User
11.3.2.6 France
11.3.2.6.1 France Dialysis Market by Type
11.3.2.6.2 France Dialysis Market by Product
11.3.2.6.3 France Dialysis Market by End User
11.3.2.7 UK
11.3.2.7.1 UK Dialysis Market by Type
11.3.2.7.2 UK Dialysis Market by Product
11.3.2.7.3 UK Dialysis Market by End User
11.3.2.8 Italy
11.3.2.8.1 Italy Dialysis Market by Type
11.3.2.8.2 Italy Dialysis Market by Product
11.3.2.8.3 Italy Dialysis Market by End User
11.3.2.9 Spain
11.3.2.9.1 Spain Dialysis Market by Type
11.3.2.9.2 Spain Dialysis Market by Product
11.3.2.9.3 Spain Dialysis Market by End User
11.3.2.10 Netherlands
11.3.2.10.1 Netherlands Dialysis Market by Type
11.3.2.10.2 Netherlands Dialysis Market by Product
11.3.2.10.3 Netherlands Dialysis Market by Test Type
11.3.2.11 Switzerland
11.3.2.11.1 Switzerland Dialysis Market by Type
11.3.2.11.2 Switzerland Dialysis Market by Product
11.3.2.11.3 Switzerland Dialysis Market by End User
11.3.2.1.12 Austria
11.3.2.12.1 Austria Dialysis Market by Type
11.3.2.12.2 Austria Dialysis Market by Product
11.3.2.12.3 Austria Dialysis Market by End User
11.3.2.13 Rest of Western Europe
11.3.2.13.1 Rest of Western Europe Dialysis Market by Type
11.3.2.13.2 Rest of Western Europe Dialysis Market by Product
11.3.2.13.3 Rest of Western Europe Dialysis Market by End User
11.4 Asia-Pacific
11.4.1 Asia-Pacific Dialysis Market by country
11.4.2 Asia-Pacific Dialysis Market by Type
11.4.3 Asia-Pacific Dialysis Market by Product
11.4.4 Asia-Pacific Dialysis Market by End User
11.4.5 China
11.4.5.1 China Dialysis Market by Type
11.4.5.2 China Dialysis Market by End User
11.4.5.3 China Dialysis Market by Product
11.4.6 India
11.4.6.1 India Dialysis Market by Type
11.4.6.2 India Dialysis Market by Product
11.4.6.3 India Dialysis Market by End User
11.4.7 Japan
11.4.7.1 Japan Dialysis Market by Type
11.4.7.2 Japan Dialysis Market by Product
11.4.7.3 Japan Dialysis Market by End User
11.4.8 South Korea
11.4.8.1 South Korea Dialysis Market by Type
11.4.8.2 South Korea Dialysis Market by Product
11.4.8.3 South Korea Dialysis Market by End User
11.4.9 Vietnam
11.4.9.1 Vietnam Dialysis Market by Type
11.4.9.2 Vietnam Dialysis Market by Product
11.4.9.3 Vietnam Dialysis Market by End User
11.4.10 Singapore
11.4.10.1 Singapore Dialysis Market by Type
11.4.10.2 Singapore Dialysis Market by Product
11.4.10.3 Singapore Dialysis Market by End User
11.4.11 Australia
11.4.11.1 Australia Dialysis Market by Type
11.4.11.2 Australia Dialysis Market by Product
11.4.11.3 Australia Dialysis Market by End User
11.4.12 Rest of Asia-Pacific
11.4.12.1 Rest of Asia-Pacific Dialysis Market by Type
11.4.12.2 Rest of Asia-Pacific Dialysis Market by Product
11.4.12.3 Rest of Asia-Pacific Dialysis Market by Test Type
11.5 Middle East & Africa
11.5.1 Middle East
11.5.1.1 Middle East Dialysis Market by country
11.5.1.2 Middle East Dialysis Market by Type
11.5.1.3 Middle East Dialysis Market by Product
11.5.1.4 Middle East Dialysis Market by End User
11.5.1.5 UAE
11.5.1.5.1 UAE Dialysis Market by Type
11.5.1.5.2 UAE Dialysis Market by Product
11.5.1.5.3 UAE Dialysis Market by End User
11.5.1.6 Egypt
11.5.1.6.1 Egypt Dialysis Market by Type
11.5.1.6.2 Egypt Dialysis Market by Product
11.5.1.6.3 Egypt Dialysis Market by End User
11.5.1.7 Saudi Arabia
11.5.1.7.1 Saudi Arabia Dialysis Market by Type
11.5.1.7.2 Saudi Arabia Dialysis Market by Product
11.5.1.7.3 Saudi Arabia Dialysis Market by End User
11.5.1.8 Qatar
11.5.1.8.1 Qatar Dialysis Market by Type
11.5.1.8.2 Qatar Dialysis Market by Product
11.5.1.8.3 Qatar Dialysis Market by End User
11.5.1.9 Rest of Middle East
11.5.1.9.1 Rest of Middle East Dialysis Market by Type
11.5.1.9.2 Rest of Middle East Dialysis Market by Product
11.5.1.9.3 Rest of Middle East Dialysis Market by End User
11.5.2 Africa
11.5.2.1 Africa Transfusion Diagnostics Market by country
11.5.2.2 Africa Dialysis Market by Type
11.5.2.3 Africa Dialysis Market by Product
11.5.2.4 Africa Dialysis Market by End User
11.5.2.5 Nigeria
11.5.2.5.1 Nigeria Dialysis Market by Type
11.5.2.5.2 Nigeria Dialysis Market by Product
11.5.2.5.3 Nigeria Dialysis Market by End User
11.5.2.6 South Africa
11.5.2.6.1 South Africa Dialysis Market by Type
11.5.2.6.2 South Africa Dialysis Market by Product
11.5.2.6.3 South Africa Dialysis Market by End User
11.5.2.7 Rest of Africa
11.5.2.7.1 Rest of Africa Dialysis Market by Type
11.5.2.7.2 Rest of Africa Dialysis Market by Product
11.5.2.7.3 Rest of Africa Dialysis Market by Test type
11.6 Latin America
11.6.1 Latin America Dialysis Market by country
11.6.2 Latin America Dialysis Market by Type
11.6.3 Latin America Dialysis Market by Technique
11.6.4 Latin America Dialysis Market by End User
11.6.5 Brazil
11.6.5.1 Brazil America Dialysis by Type
11.6.5.2 Brazil America Dialysis by Technique
11.6.5.3 Brazil America Dialysis by End User
11.6.6 Argentina
11.6.6.1 Argentina America Dialysis by Type
11.6.6.2 Argentina America Dialysis by Technique
11.6.6.3 Argentina America Dialysis by End User
11.6.7 Colombia
11.6.7.1 Colombia America Dialysis by Type
11.6.7.2 Colombia America Dialysis by Technique
11.6.7.3 Colombia America Dialysis by End User
11.6.8 Rest of Latin America
11.6.8.1 Rest of Latin America Dialysis by Type
11.6.8.2 Rest of Latin America Dialysis by Technique
11.6.8.3 Rest of Latin America Dialysis by End User
12. Company profile
12.1 Asahi Kasei
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.1.5 The SNS View
12.2 Nikkiso
12.2.1 Company Overview
12.2.2 Financials
12.2.3 Product/Services Offered
12.2.4 SWOT Analysis
12.2.5 The SNS View
12.3 Fresenius Se and CO
12.3.1 Company Overview
12.3.2 Financials
12.3.3 Product/Services Offered
12.3.4 SWOT Analysis
12.3.5 The SNS View
12.4 KGAA
12.4.1 Company Overview
12.4.2 Financials
12.4.3 Product/Services Offered
12.4.4 SWOT Analysis
12.4.5 The SNS View
12.5 Nipro Corporation
12.5.1 Company Overview
12.5.2 Financials
12.5.3 Product/Services Offered
12.5.4 SWOT Analysis
12.5.5 The SNS View
12.6 Becton, Dickinson and Company
12.6.1 Company Overview
12.6.2 Financials
12.6.3 Product/Services Offered
12.6.4 SWOT Analysis
12.6.5 The SNS View
12.7 Diaverum
12.7.1 Company Overview
12.7.2 Financials
12.7.3 Product/Services Offered
12.7.4 SWOT Analysis
12.7.5 The SNS View
12.8 Deutschland
12.8.1 Company Overview
12.8.2 Financials
12.8.3 Product/Services Offered
12.8.4 SWOT Analysis
12.8.5 The SNS View
12.9 Baxter International
12.9.1 Company Overview
12.9.2 Financials
12.9.3 Product/Services Offered
12.9.4 SWOT Analysis
12.9.5 The SNS View
12.10 B Braun Melesungen
12.10.1 Company Overview
12.10.2 Financials
12.10.3 Product/Services Offered
12.10.4 SWOT Analysis
12.10.5 The SNS View
13. Competitive Landscape
13.1 Competitive Bench marking
13.2 Market Share Analysis
13.3 Recent Developments
13.3.1 Industry News
13.3.2 Company News
13.3.3 Mergers & Acquisitions
14. Use Case and Best Practices
15. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
The Oral Syringes Market size was USD 350.0 Million in 2023 and is expected to reach USD 1092.57 Million by 2032 and grow at a CAGR of 4.3% by 2024-2032.
The Biosimulation Market Size was valued at USD 2.4 billion in 2023 and is expected to reach USD 8.4 billion by 2031, and grow at a CAGR of 17.0% over the forecast period 2024-2031.
The Generative AI in Healthcare Market size was valued at US$ 1.7 Bn in 2023 and is estimated to US$ 19.99 Bn by 2032 with a growing CAGR of 31.5% Over the Forecast Period of 2024-2032.
The Blood Pressure Cuffs Market size was valued at USD 192.81 Million in 2023 and is expected to reach USD 355.00 Million by 2032 and grow at a CAGR of 7.04% over the forecast period 2024-2032.
The Smart Hospitality Market is anticipated to increase at a CAGR of 30% from 2024 to 2032, from a value of USD 17.55 billion in 2023 and expected to reach USD 186.10 billion by 2032.
The global pharmaceutical logistics market, valued at USD 92.20 Billion in 2023, is projected to reach USD 201.99 Billion by 2032, growing at a compound annual growth rate CAGR of 9.59% during the forecast period.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
